English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    S. P. Guranych, E. M. Tsymbala, V. B. Stetseviat, T.V. Todoriv, I. M. Danyliuk, T. V. Guranych, N. M. Voronych-Semchenko

    METABOLIC POLYORGANIC DISORDERS IN RATS WITH INSULIN RESISTANCE ON THE BACKGROUND OF IODINE DEFICIENCY


    About the author: S. P. Guranych, E. M. Tsymbala, V. B. Stetseviat, T.V. Todoriv, I. M. Danyliuk, T. V. Guranych, N. M. Voronych-Semchenko
    Heading EXPERIMENTAL MEDICINE
    Type of article Scentific article
    Annotation Impaired glucose tolerance leads to structural and functional restructuring of internal organs, that intensify under iodine deficiency conditions. Studies were carried on male rats (animals with insulin resistance under conditions of adequate iodine supply and iodine deficiency). Metabolic changes were studied in blood serum, homogenates of kidneys, heart, liver, teeth pulp and oral mucosa. It is established that development of insulin resistance is accompanied by activation of lipoperoxidation processes in studied organs, decrease of catalase activity and increased glutathione defense system. In animals signs of visceral obesity are developed, manifested by increase of atherogenic index and leptin level, decrease of ghrelin concentration in blood serum. Under conditions of combined endocrinopathy increase of lipoperoxide products in tissues on the background of antioxidant reserve inhibition, growth of proatherogenic lipid fractions relative to data in animals with isolated insulin resistance are observed, that reflects potentiation of pathological changes under conditions of combined endocrinopathy.
    Tags thyroid hormones, insulin, ghrelin, leptin, lipids, oxidative stress, antioxidant system
    Bibliography
    • Barna OM, Novytska AV, Sabadash VYe, Pohrebniak OO. Pechinka v kontynuumi metabolichnoho syndromu. Medicine of Ukraine. 2018;4(220):40–5. [in Ukranian]
    • Bolshova OV, Malinovska TM. Vmist hrelinu ta leptynu v plazmi krovi v ditei ta pidlitkiv iz dysfunktsiieiu hipotalamusa. International Journal of Endocrynology. 2018;14(8):719–24. doi: http://dx.doi.org/10.22141/2224-0721.14.8.2018.154849. [in Ukranian]
    • Voronych-Semchenko NM, Huranych TV. Zminy procesiv vilnoradykalnogo okysnennia lipidiv i bilkiv, antyoksydantnogo zahystu u shchuriv iz hipofunkciieiu shchutopodibnoi zalozyna tli deficytu iodu і midi. Fiziolohichnyy Zhurnal. 2014;60(4):30–39. [in Ukranian]
    • Hnatush AR, Drel VR, Yalaneckyy AYa, Mizin VI, Zagoruyko VA, Gerzhykova VG et al. Antyoksydantnyi efekt pryrodnykh polifenolnykh kompleksiv vynohradu u sitkivtsi oka shchuriv zi tsukrovym diabetom, indukovanym streptozototsynom. Studia Biologica. 2011;5(2):61–72. DOI: https://doi.org/10.30970/sbi.0502.156. [in Ukrainian]
    • Didushko OM. Vplyv insulinorezystentnosti na funktsiiu nyrok u khvorykh na pervynnyi hipotyreoz. Mezhdunarodnyi endokrynolohycheskyi zhurnal. 2015;4(68):24–7. [in Ukranian]
    • Kikhtyak OP, Lishchuk OZ, Moskva KhA. Vyvchennia efektyvnosti dii insulinovykh sensytaizeriv na vuhlevodnyi ta lipidnyi obmin u khvorykh z dyfuznym toksychnym zobom ta insulinorezystentnistiu. Zdobutky klinichnoi i eksperymetalnoi medytsyny. 2016;4:51–5. [in Ukranian]
    • Kudriavtsev AA. Rol ta mistse hrelinu u patolohii zakhvoriuvan orhaniv shlunkovokyshkovoho traktu. Skhidnoievropeiskyi zhurnal vnutrishnoi ta simeinoi medytsyny. 2019;2:90–100. doi: 10.15407/internalmed2019.02.090. [in Ukranian]
    • Lavrenova EA, Drapkyna OM. Insulinorezystentnost pri ozhyrenii: prichiny i posledstviia. Ozhyrenie i metabolyzm. 2020;17(1):48–55. https://doi.org/10.14341/omet9759. [in Russian]
    • Sokoliuk TV, Horbenko NI, Merzlikin SI, Podhainyi DH. Doslidzhennia vplyvu diakamfu na oksydatyvnyi stres za umov eksperymentalnoho tsukrovoho diabetu ta metabolichnoho syndromu. Ukrainskyi  zhurnal klinichnoyi ta laboratornoyi medytsyny. 2009;4(20):105–9. [in Ukranian]
    • Shuprovych AA. Violation of uric acid metabolism in rats with experimental insulin resistant syndrome induced by fructose. Fiziolohichnyy Zhurnal. 2011;57(1):72–81.
    • Dunn J, Grutchfield H, Gutekunst R. Two simple methods for measuring iodine in urine. Thyroidology. 1993;3:119–23. doi: 10.1089/thy.1993.3.119.
    • Hossan T, Kundu S, Alam SS, Nagarajan S. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus. Endocr. Metab. Immune Disord. Drug Targets. 2019;19(6):775–86. doi: 10.2174/1871530319666190301145545.
    • Kozar VV, Yeromenko RF, Dolzhykova OV, Horbenko NI, Kudria MYa, Yaremenko FH. Zmina kontsentratsii leptynu v ovariektomovanykh shchuriv iz metabolichnym syndromom za umov vvedennia spoluk z imunomoduliuiuchoiu aktyvnistiu. Ukrainskyi zhurnal medytsyny, biolohiyi ta sportu. 2018;3(1(10)):40–3. doi: 10.26693/JMBS03.01.040.
    • Martijn JL Verhulst, Bruno G Loos, Victor EA Gerdes, Wijnand J Teeuv. Evaluating all potential oral complications of diabetes mellitus. Front. Endocrinollogy. 2019;1:154–67. doi: 10.3389/fendo.2019.00056.
    Publication of the article «World of Medicine and Biology» №3(77), 2021 year, 208-214 pages, index UDK 616-098+616-092.9+616.379-008.64+546.15
    DOI 10.26724/2079-8334-2021-3-77-208-214